Funding shortfall
The company has no firm financing arrangements and needs capital to continue development.
- Scope
- Operations and commercialization
- Materiality
- high
Quantum Genesis AI Corp.
Quantum Genesis AI Corp. is a U.S.-based development-stage biotechnology and industrial chemistry company focused on engineered enzymes for biotransformation and sustainable chemical manufacturing. Its work centers on applying quantum mechanics, molecular modeling, and enzyme engineering to improve chemical processes for pharmaceutical and other specialty-chemicals applications.
0.00
0.00
| % | |
|---|---|
| Engineered enzymes | 60% Custom-designed enzymes intended to improve selectivity, activity, and specificity in chemical processes. |
| API biotransformation applications | 25% Enzyme-based process tools for active pharmaceutical ingredient manufacturing. |
| Sustainable chemistry R&D | 15% Research programs aimed at extending enzyme platforms into green chemistry use cases. |
The company’s target customers are pharmaceutical manufacturers and other chemical producers that need more selective,...
- Pharmaceutical API manufacturersprimary
Buy engineered enzymes to support active pharmaceutical ingredient production and improve process selectivity.
- Specialty chemical producerssecondary
Use enzyme platforms for cleaner, more efficient manufacturing in fragrances, flavors, and related chemistries.
- Sustainability-focused industrial usersemerging
Explore enzyme applications in plastic degradation, carbon capture, and sustainable materials.
- Strategic partners and licensorsprimary
May fund development, provide scale-up support, or commercialize the technology through alliances.
The company is headquartered in San Diego, California, and its disclosed operations are U.S.-based...
- •Headquartered in San Diego, California
- •Primary operations are research and development in the United States
- •Uses third-party testing facilities on an as-needed basis
- •Depends on contract manufacturers for larger-scale enzyme production
- •No country-level revenue disclosure because the company has no revenue
The company’s strategy is to advance engineered-enzyme technology from research into commercial use, starting with...
01
Commercialize enzyme platforms in API productionshort-term
Initial market focus provides a clear industrial use case and validation path for the technology.
02
Expand into adjacent specialty-chemicals marketsmedium-term
Fragrances, flavors, and sustainable chemistry broaden the addressable market beyond pharma.
03
Establish strategic alliances and advisory depthmedium-term
Partnerships and scientific oversight can improve credibility, access, and commercialization speed.
The business is highly dependent on external funding, because it is still in development and has not generated revenue...
Third-party manufacturing dependence
Large-scale enzyme production is outsourced, creating supply, timing, and quality exposure.
- Scope
- Product availability and scale-up
- Materiality
- high
Key-person dependence
The company is early-stage and has a very small workforce, increasing reliance on a few individuals.
- Scope
- Scientific and operational continuity
- Materiality
- high
Testing facility access constraints
The company relies on off-site testing facilities without formal agreements.
- Scope
- R&D timelines and costs
- Materiality
- medium
Regulatory and legal changes
Biotransformation and chemical applications are exposed to evolving industry regulation.
- Scope
- Market access and compliance
- Materiality
- medium
Going concern
Affects financial statement presentation and investor assessment of survival risk
Equity issuance and dilution accounting
Affects shareholders' equity and dilution analysis
Stock-based compensation
Can materially affect operating expenses
Interest expense on debt
Affects other expense and cash flow
Quantum-Si Inc
QSI · Measuring & Controlling Devices, NEC
Kinetic Seas Inc.
KSEZ · Blank Checks
GENESIS ENERGY LP
GEL · Pipe Lines (No Natural Gas)
Quantum Computing Inc.
QUBT · Services-Prepackaged Software
Qnity Electronics, Inc.
Q · Semiconductors & Related Devices
CODEXIS, INC.
CDXS · Industrial Organic Chemicals
: 29/04/2026